[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338246-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-338246-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","the-up-regulation-of-pak2-indicates-unfavorable-prognosis-in-patients-with-serous-epithelial-ovarian-cancer-and-contributes-to-paclitaxel-resistance-in-ovarian-cancer-cells","The up-regulation of PAK2 indicates unfavorable prognosis in patients with serous epithelial ovarian cancer and contributes to paclitaxel resistance in ovarian cancer cells","","Ovarian cancer treatment is limited by chemotherapy resistance, and prior work links PAK2 to expression changes across tumors. This study evaluates whether increased PAK2 promotes chemo-resistance and worsened outcomes in serous epithelial ovarian cancer. Bioinformatics findings are validated with tissue microarrays, and clinical correlations are tested by logistic regression, Cox models, and Kaplan-Meier analysis. Cellular assays assess effects of PAK2 inhibition on paclitaxel sensitivity, and mechanistic studies examine the PAK2-related lnc-SNHG1/miR-216b-5p axis via RIP, luciferase, and rescue experiments.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-up-regulation-of-pak2-indicates-unfavorable-prognosis-in-patients-with-serous-epithelial-ovarian-cancer-and-contributes-to-paclitaxel-resistance-in-ovarian-cancer-cells/338246/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-up-regulation-of-pak2-indicates-unfavorable-prognosis-in-patients-with-serous-epithelial-ovarian-cancer-and-contributes-to-paclitaxel-resistance-in-ovarian-cancer-cells/338246.png","ImageObject",300,407,{"name":42,"@type":43},"Riley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main clinical problem addressed in this research?","Question",{"text":63,"@type":64},"The study focuses on chemotherapy resistance in ovarian cancer, which leads to poor patient outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers assess the role of PAK2 in prognosis and resistance?",{"text":68,"@type":64},"They combined bioinformatics analyses with tissue microarray validation, then used logistic regression, Cox regression, and Kaplan-Meier analyses for clinical prognostic evaluation.",{"name":70,"@type":61,"acceptedAnswer":71},"What experimental evidence supports a link between PAK2 and paclitaxel resistance?",{"text":72,"@type":64},"In vitro assays showed that downregulating PAK2 reduced colony formation, increased apoptosis, and weakened cell invasion in A2780/Taxol cells, consistent with increased paclitaxel sensitivity.",{"name":74,"@type":61,"acceptedAnswer":75},"What mechanism involving lnc-SNHG1, miR-216b-5p, and PAK2 is proposed?",{"text":76,"@type":64},"The study reports that lnc-SNHG1 acts as a competitive endogenous RNA and modulates the miR-216b-5p/PAK2 axis, with rescue experiments indicating this axis drives paclitaxel resistance.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},338246,1790862623,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,104,109,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":101,"show_sort_weight":102,"slug":103},"Comic",60,"comic",{"id":105,"doc_module":4,"doc_module_name":25,"category_name":106,"show_sort_weight":107,"slug":108},6,"Technology",50,"technology",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},7,"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":55,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Shuang etal. BMC Cancer (2024) 24:1213 BMC Cancer  \n[https://doi.org/10.1186/s12885-024-12969-1](https://doi.org/10.1186/s12885-024-12969-1)  \nRESEARCH Open Access  \nThe up-regulation of PAK2 indicates   \nunfavorable prognosis in patients with serous epithelial ovarian cancer and contributes to paclitaxel resistance in ovarian cancer cells  \nTing Shuang 1*, Shiyun Wu 1, Yifei Zhao 1, Yanqi Yang 1,2 and Meili Pei 1*  \nAbstract  \nBackground The main challenge in treating ovarian cancer is chemotherapy resistance. Previous studies have shown that PAK2 is highly expressed in various cancers. This research investigates whether increased PAK2 expression contributes to chemo-resistance and poor prognosis in ovarian cancer.  \nMethods Initially, bioinformatics analysis was used to assess the importance of PAK2 mRNA up-regulation in ovarian cancer. This was then validated using tissue microarray to confirm PAK2 protein expression and localization in clinical samples. Univariate and multivariate logistic regression analyses were carried out to identify potential risk factors for chemo-resistance in serous epithelial ovarian cancer (EOC), while multivariate Cox regression and Kaplan-Meier analysis were conducted to ascertain prognostic factors for overall survival (OS) and disease-free survival (DFS) inpatients with serous EOC. In vitro experiments were conducted to verify if inhibiting PAK2 expression could increase A2780/Taxol cells’ sensitivity to paclitaxel, as shown by evaluating cell proliferation, apoptosis, transwell, and clone formation. Additionally, the interaction between PAK2, l nc-SNHG1, and miR-216b-5p was verified using RIP and luciferase reporter assays. Rescue experiments were undertaken to examine the influence ofthe l nc-SNHG1/miR- 216b-5p/PAK2 axis on the development of paclitaxel resistance in A2780/Taxol cells.  \nResults The bioinformatics analysis indicated a notable increase in PAK2 expression in ovarian malignant tumors compared to adjacent tissues, particularly in patients with stage III-IV disease compared to those with stage I-II disease (P = 0 . 0056) . Elevated levels of PAK2 were linked to reduced OS in ovarian cancer patients, although no significant association was observed with DFS. Immunohistochemistry findings further supported these results, showing positive PAK2 protein expression in chemo-resistant serous EOC tissues, predominantly localized in the cytoplasm, which correlated with poorer OS and DFS outcomes. In vitro experiments demonstrated that the downregulation of PAK2 in A2780/Taxol cells led to a reduction in colony formation, an increase in apoptosis, and a diminished capacity for cell invasion. Subsequent analysis confirmed that l nc-SNHG1 functions as a competitive endogenous RNA (ceRNA)  \n*Correspondence:  \nTing Shuang[shuangting87@163.com](shuangting87@163.com)[ ](shuangting87@163.com)Meili Pei [peiml@xjtufh.edu.cn](peiml@xjtufh.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [ht","cbCaisH3ZTvm0Zey","https://ap.wps.com/l/cbCaisH3ZTvm0Zey","pdf",9352986,15,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the main clinical problem addressed in this research?\",\"answer\":\"The study focuses on chemotherapy resistance in ovarian cancer, which leads to poor patient outcomes.\"},{\"question\":\"How did the researchers assess the role of PAK2 in prognosis and resistance?\",\"answer\":\"They combined bioinformatics analyses with tissue microarray validation, then used logistic regression, Cox regression, and Kaplan-Meier analyses for clinical prognostic evaluation.\"},{\"question\":\"What experimental evidence supports a link between PAK2 and paclitaxel resistance?\",\"answer\":\"In vitro assays showed that downregulating PAK2 reduced colony formation, increased apoptosis, and weakened cell invasion in A2780/Taxol cells, consistent with increased paclitaxel sensitivity.\"},{\"question\":\"What mechanism involving lnc-SNHG1, miR-216b-5p, and PAK2 is proposed?\",\"answer\":\"The study reports that lnc-SNHG1 acts as a competitive endogenous RNA and modulates the miR-216b-5p/PAK2 axis, with rescue experiments indicating this axis drives paclitaxel resistance.\"}]","The up-regulation of PAK2 indicates unfavorable prognosis in patients with serous epithelial ovarian cancer and contributes to paclitaxel resistance in ovarian cancer cells | PDF",1790022726,38,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0fdfa0339c9f195b07b807ab1592cef.webp",983,1310,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4dac2b241fb1309768e81826cc8296b.webp",982,1309,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5fb50e898d1a471d439f339080d50c0.webp",981,1308,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/244ec9d5d2d50f706c5c1278b82f5fb2.webp",980,1306]